Are you Dr. Itescu?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 30 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
177 Fort Washington Ave
7-453gn
New York, NY 10032Phone+1 201-447-8717Fax+1 201-251-3300- Is this information wrong?
Summary
- Dr. Silviu Itescu, MD is an allergist/immunologist in New York, New York.
Education & Training
- NYU Grossman School of MedicineFellowship, Rheumatology, 1987 - 1990
- NYU Grossman School of MedicineResidency, Internal Medicine, 1984 - 1986
- New York Medical College (Metropolitan)Internship, Internal Medicine, 1983 - 1984
- Monash University Faculty of MedicineClass of 1981
Publications & Presentations
PubMed
- 13 citationsA Randomized Trial of Mesenchymal Stromal Cells for Moderate to Severe Acute Respiratory Distress Syndrome from COVID-19.Michael E Bowdish, Christina E Barkauskas, Jessica R Overbey, Robert L Gottlieb, Keren Osman, Abhijit Duggal, Mary E Marks, Jonathan Hupf, Eustace Fernandes, Bradley G...> ;American Journal of Respiratory and Critical Care Medicine. 2023 Feb 1
- 15 citationsRGDfK-Peptide Modified Alginate Scaffold for Cell Transplantation and Cardiac Neovascularization.Hugo P. Sondermeijer, Piotr Witkowski, Tetsunori Seki, Arnoud van der Laarse, Silviu Itescu, M. A. Hardy> ;Tissue Engineering. Part A. 2017 Nov 13
- 38 citationsSafety, tolerability, clinical, and joint structural outcomes of a single intra-articular injection of allogeneic mesenchymal precursor cells in patients following ant...Yuanyuan Wang, Andrew Shimmin, Peter Ghosh, Paul Marks, James M. Linklater, David Connell, Stephen Hall, Donna Skerrett, Silviu Itescu, Flavia M. Cicuttini> ;Arthritis Research & Therapy. 2017 Aug 2
- Join now to see all
Press Mentions
- Longevity Investment Bulletin: Therini Bio, Calico, Alchemab and MoreApril 28th, 2023
- DREAM-HF Phase 3 Trial Results for Mesoblast Cell Therapy in Heart Failure Published in Journal of the American College of Cardiology (JACC)February 27th, 2023
- DREAM-HF Phase 3 Trial Results for Mesoblast Cell Therapy in Heart Failure Published in Journal of the American College of Cardiology (JACC)February 27th, 2023
- Join now to see all